60 Degrees Pharmaceuticals SXTP Income Statement (2022-2026)

NASDAQ SXTP
$1.13 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.50M0.17M0.02M0.40M0.05M0.27M0.11M0.12M0.14M0.24M0.16M0.10M0.44M0.30M0.16M
Cost of Revenue (Quarter) 0.09M0.09M0.16M0.07M0.18M0.07M0.15M0.07M0.09M0.11M0.12M0.07M0.05M0.54M0.12M0.09M
Gross Profit (Quarter) 0.42M0.08M-0.16M-0.06M-0.12M-0.02M-0.02M0.04M0.04M0.02M0.12M0.09M0.05M-0.10M0.18M0.08M
Operating items
Research & Development (Quarter) 0.23M0.03M0.20M0.12M0.20M0.26M0.10M0.34M3.10M0.94M0.61M0.37M0.25M0.81M0.64M0.28M
Selling, General & Administrative (Quarter) 0.41M0.41M0.31M0.78M0.46M1.31M1.69M1.08M1.13M1.22M1.61M1.72M1.61M1.51M1.47M1.89M
Other Operating Expenses (Quarter) -0.05M0.34M730.00-0.07M5.45M0.02M0.02M
Operating Expenses (Quarter) 0.64M0.44M0.51M0.90M0.67M1.58M1.79M1.41M4.22M2.16M2.22M2.09M1.86M2.32M2.11M2.17M
Operating Income (Quarter) -0.69M-0.22M-0.68M-0.95M-0.79M-1.52M-1.89M-1.34M-4.19M-2.12M-2.07M-1.91M-1.60M-2.33M-1.92M-2.09M
EBIT (Quarter) -0.69M-0.22M-0.68M-0.95M-0.79M-1.52M-1.89M-1.34M-4.19M-2.12M-2.07M-1.91M-1.60M-2.33M-1.92M-2.09M
Non-operating items
Non Operating Investment Income (Quarter) -0.04M0.08M-0.12M-0.02M
Other Non Operating Income (Quarter) -0.02M0.14M-0.84M0.01M0.09M0.03M0.02M0.02M0.37M0.03M0.01M0.03M0.02M0.01M
Non Operating Income (Quarter) 5.70M-0.15M1.77M0.01M-0.04M0.02M0.03M-0.13M0.01M0.48M0.00M
Net income details
EBT (Quarter) -2.15M-1.45M-1.67M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M-0.98M-2.09M
Tax Provisions (Quarter) 250.00250.00-1.30M63.0063.0063.0061.0063.00438.00250.00-1.67M63.000.00M250.00-0.00M
Profit After Tax (Quarter) -2.15M-1.45M4.61M-2.60M-3.34M4.18M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M-1.44M-2.09M
Income from Non-Controlling Interests (Quarter) -0.00M-0.00M0.01M0.00M-0.01M-0.01M-0.03M-0.00M-0.00M-713.00-0.00M-752.00-0.00M-712.00-499.00-941.00
Income from Continuing Operations (Quarter) -2.15M-1.45M-0.37M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-0.38M-1.88M-1.73M-2.32M-0.98M-2.09M
Consolidated Net Income (Quarter) -2.15M-1.45M-0.37M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-0.38M-1.88M-1.73M-2.32M-0.98M-2.09M
Income towards Parent Company (Quarter) -2.15M-1.45M-0.37M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-0.38M-1.88M-1.73M-2.32M-0.98M-2.09M
Preferred Dividend Payments (Quarter) 0.10M0.12M0.12M0.12M0.12M0.13M0.12M
Net Income towards Common Stockholders (Quarter) -2.15M-1.45M-1.66M-2.60M-3.34M4.09M-2.08M0.31M-4.29M-2.27M-2.18M-2.00M-1.73M-2.32M-0.98M-2.09M
Additional items
EPS (Basic) (Quarter) -219.64-146.20-167.95-270.97-336.79184.59-125.897.32-84.50-18.60-19.18-6.25-4.71-2.52-1.46-1.21
EPS (Diluted) (Quarter) -219.64-146.20-167.95-270.97-336.79184.59-125.897.32-84.50-18.60-19.18-6.25-4.71-2.52-1.46-1.21
Shares Outstanding (Quarter) 0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.04M0.05M0.12M0.11M0.32M0.37M0.92M0.67M1.73M
Shares Outstanding (Diluted) (Quarter) 0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.04M0.05M0.12M0.11M0.32M0.37M0.92M0.67M1.73M
Shares Outstanding (Entity) (Quarter) 0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.05M0.05M0.12M0.11M0.37M0.37M1.03M0.67M1.73M
EBITDA (Quarter) -0.69M-0.22M-0.68M-0.95M-0.79M-1.52M-1.89M-1.34M-4.19M-2.12M-2.07M-1.91M-1.60M-2.33M-1.92M-2.09M
Interest Expenses (Quarter) 0.03M1.22M-0.08M1.14M0.03M0.00M0.06M0.01M0.01M0.00M0.04M0.04M0.04M0.00M0.01M
Tax Rate (Quarter) -0.01%-0.02%77.73%0.00%0.00%0.00%0.00%0.01%-0.01%-0.01%81.54%0.00%-0.09%-0.01%0.18%